Infusion centers across the state will not be able to offer monoclonal antibody treatments for COVID-19 omicron patients until next month.
12News Now Beaumont's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
Names this update
Texas exhausts supply of monoclonal antibody treatment as omicron cases surge
Headline from 12News Now Beaumont ·
Newest
5 large Texas centers run out of monoclonal antibody treatment, overall supplies dwindling
EL PASO, Texas – The Texas Department of State Health Services (DSHS) said Monday that the infusion center in El Paso - as well as those in Austin, El Paso, Fort Worth, San Antonio - have exhausted their supply of sotrovimab, the monoclonal antibody that's effective against the Covid-19 Omicron vari…
Sotrovimab, the treatment that many centers in Texas are now out of, is the only antibody treatment so far to be effective against the COVID-19 Omicron variant.
The state health department has run out of a key treatment to fight the omicron COVID-19 variant, which now makes up 90% of the virus cases in Texas. On Monday,
Texas has run out of its supply of monoclonal antibodies, and infusion centers in the state will be unable to offer the treatment until more shipments are sent out in January.
Infusion centers in five large Texas metros have exhausted their supply of the antibody drug that is most effective against the more-transmissible omicron variant.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Texas exhausts supply of monoclonal antibody treatment as omicron cases surge | Since Then
